health News

Stinky feet may lead to better malaria traps
Associated Press: London, Jun 04, 2013 at 1824 hrs ISTScientists say there might be potent new tool to fight deadly mosquito-borne disease.
Sun Pharma gets USFDA nod for testosterone cypionate injection
PTI: New Delhi, Jun 04, 2013 at 1710 hrs ISTThe approval is for the product in the strengths of 100 mg/ml and 200mg/ml, it added.
Our current drugs in India, global markets safe: Ranbaxy
PTI: New Delhi, May 31, 2013 at 1411 hrs ISTCompany's move follows reports of a circular by Mumbai's Jaslok Hospital.
New solution for prostate cancer treatment found
PTI: Melbourne, May 30, 2013 at 1439 hrs ISTResearchers found that some prostate cancer cells survive androgen withdrawal treatment.
AstraZeneca buys heart firm Omthera Pharmaceuticals for up to $443 m
Reuters: London, May 29, 2013 at 2031 hrs ISTAstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain’s second-biggest drugmaker.
Sun Pharma Q4 net profit up 23% at Rs 1,011.56 cr
Press Trust of India: New Delhi, May 28, 2013 at 1911 hrs ISTSun Pharmaceutical Industries today reported 23.32 per cent increase in consolidated net profit.

Ads by Google

Statins can slash arthritis risk
London, May 28, 2013 at 1643 hrs ISTA daily dose of statins can more than halve the risk of developing arthritis
Cancers can be stopped before they develop, says Indian-origin scientist
Press Trust of India: Washington, May 27, 2013 at 1711 hrs ISTScientists, including one of Indian-origin, have uncovered a mechanism which may stop tumours.
FDA crackdown on Indian drug firms no witch hunt
Jayati Ghose: New Delhi, May 25, 2013 at 0311 hrs ISTIndia's generic drug industry can't grudge FDA its actions against some of the poster boys.
For Ranbaxy Laboratories shares, Daiichi Sankyo's pill seems tough to swallow
fe Bureau: Mumbai, May 24, 2013 at 0123 hrs ISTShares of India’s biggest drugmaker, Ranbaxy, plunged 8.8% to close at Rs 393.15 on Thursday.
Ranbaxy Laboratories' Malvinder Singh likely to be sued by Daiichi Sankyo
fe Bureau: New Delhi, May 23, 2013 at 0124 hrs ISTDaiichi Sankyo says former shareholders of Ranbaxy Lab 'concealed critical information'.
Timing of cancer radiation therapy may minimise hair loss
PTI: Washington, May 21, 2013 at 1539 hrs ISTHair loss in humans from toxic cancer radiotherapy and chemotherapy might be minimised.
Drug pricing order hits few, helps many
fe Bureau: New Delhi, May 17, 2013 at 0221 hrs ISTRoughly 28% of the R70,000-crore Indian pharmaceutical market will soon come under a benign market-based price regulation as against 18% under the existing opaque cost-based control regime
Ranbaxy Laboratories 'systematically violated' practices: Whistleblower Dinesh Thakur
Press Trust of India: Washington, May 14, 2013 at 1852 hrs ISTWhistleblower Thakur will receive $48.6 mn from the $500 mn penalty imposed on Ranbaxy.

Previous | Next

More Headlines